TAIMEI TECH Buys Back 20,000 H Shares at HKD 4.84–4.995; Free-Float Down 0.01%

Bulletin Express

Sep 21

Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) disclosed a share repurchase conducted on 21 September 2026 under its Hong Kong listing (stock code 02576).

The company acquired 20,000 H shares on the Hong Kong Stock Exchange, paying between HKD 4.84 and HKD 4.995 per share for a volume-weighted average price of HKD 4.9239. Total consideration reached HKD 0.10 million.

Following the transaction, the number of issued shares (excluding treasury shares) fell to 193.37 million from 193.39 million—an incremental reduction of 0.01%. Treasury shares rose to 7.22 million, while aggregate issued shares remained unchanged at 200.59 million.

The repurchase forms part of the mandate approved on 23 June 2026, which allows TAIMEI TECH to buy back up to 20.02 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 3.4% of the company’s issued share capital on the mandate date. A 30-day moratorium restricts any new share issuance or sale of treasury shares until 21 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/news/1130633977"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130633977\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130633977?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-21 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130633977","market":"hk","top_or_hot":-1,"title":"TAIMEI TECH Buys Back 20,000 H Shares at HKD 4.84–4.995; Free-Float Down 0.01%","media":"Bulletin Express","content":"<p>Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) disclosed a share repurchase conducted on 21 September 2026 under its Hong Kong listing (stock code 02576).</p>\n<p>The company acquired 20,000 H shares on the Hong Kong Stock Exchange, paying between HKD 4.84 and HKD 4.995 per share for a volume-weighted average price of HKD 4.9239. Total consideration reached HKD 0.10 million.</p>\n<p>Following the transaction, the number of issued shares (excluding treasury shares) fell to 193.37 million from 193.39 million—an incremental reduction of 0.01%. Treasury shares rose to 7.22 million, while aggregate issued shares remained unchanged at 200.59 million.</p>\n<p>The repurchase forms part of the mandate approved on 23 June 2026, which allows TAIMEI TECH to buy back up to 20.02 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 3.4% of the company’s issued share capital on the mandate date. A 30-day moratorium restricts any new share issuance or sale of treasury shares until 21 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TAIMEI TECH Buys Back 20,000 H Shares at HKD 4.84–4.995; Free-Float Down 0.01%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTAIMEI TECH Buys Back 20,000 H Shares at HKD 4.84–4.995; Free-Float Down 0.01%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-21 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) disclosed a share repurchase conducted on 21 September 2026 under its Hong Kong listing (stock code 02576).</p>\n<p>The company acquired 20,000 H shares on the Hong Kong Stock Exchange, paying between HKD 4.84 and HKD 4.995 per share for a volume-weighted average price of HKD 4.9239. Total consideration reached HKD 0.10 million.</p>\n<p>Following the transaction, the number of issued shares (excluding treasury shares) fell to 193.37 million from 193.39 million—an incremental reduction of 0.01%. Treasury shares rose to 7.22 million, while aggregate issued shares remained unchanged at 200.59 million.</p>\n<p>The repurchase forms part of the mandate approved on 23 June 2026, which allows TAIMEI TECH to buy back up to 20.02 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 3.4% of the company’s issued share capital on the mandate date. A 30-day moratorium restricts any new share issuance or sale of treasury shares until 21 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02576","symbol_name":"太美医疗科技","start_time":0,"source_url":"","article_id":"1130633977","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130633977","pubTimestamp":1789997087,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) disclosed a share repurchase conducted on 21 September 2026 under its Hong Kong listing (stock code 02576). The company acquired 20,000 H...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02576":"太美医疗科技"},"translate_title":"泰美科技以4.84-4.995港元回购20,000股H股；自由浮动下跌 0.01%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02576":1},"content_text":"Zhejiang Taimei Medical Technology Co., Ltd. (“TAIMEI TECH”) disclosed a share repurchase conducted on 21 September 2026 under its Hong Kong listing (stock code 02576).\nThe company acquired 20,000 H shares on the Hong Kong Stock Exchange, paying between HKD 4.84 and HKD 4.995 per share for a volume-weighted average price of HKD 4.9239. Total consideration reached HKD 0.10 million.\nFollowing the transaction, the number of issued shares (excluding treasury shares) fell to 193.37 million from 193.39 million—an incremental reduction of 0.01%. Treasury shares rose to 7.22 million, while aggregate issued shares remained unchanged at 200.59 million.\nThe repurchase forms part of the mandate approved on 23 June 2026, which allows TAIMEI TECH to buy back up to 20.02 million shares. Cumulative repurchases under this mandate now stand at 6.80 million shares, equivalent to 3.4% of the company’s issued share capital on the mandate date. A 30-day moratorium restricts any new share issuance or sale of treasury shares until 21 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}